"Midway Research Center is at the forefront of clinical trials and cutting edge treatment. If you are eligible, you may receive study drugs, labs, and medical treatments related to the study at no cost."

During the past decade, Midway Immunology and Research Center conducted 35 clinical trials. In the 10-year time frame, 35 clinical trials started and 36 clinical trials were completed, i.e. on average, 102.9% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 12 clinical trials were completed. i.e. 85.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Midway Immunology and Research Center" #1 sponsor was "Gilead Sciences" with 40 trials, followed by "TaiMed Biologics Inc." with 3 trials sponsored, "Janssen Scientific Affairs, LLC" with 2 trials sponsored, "AbbVie" with 1 trials sponsored and "Aevi Genomic Medicine, LLC, a Cerecor company" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Midway Immunology and Research Center" #1 collaborator was "Janssen Research & Development, LLC" with 1 trials as a collaborator, "Merck Sharp & Dohme LLC" with 1 trials as a collaborator and "Westat" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Midway Immunology and Research Center" are "HIV-1 Infection" (19 trials), "HIV Infections" (13 trials), "HIV" (10 trials), "HIV-1-infection" (8 trials) and "Acquired Immunodeficiency Syndrome" (6 trials). Many other conditions were trialed in "Midway Immunology and Research Center" in a lesser frequency.

Most popular intervention types in "Midway Immunology and Research Center" are "Drug" (51 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "E/C/F/TAF" (12 trials), "B/F/TAF" (9 trials), "ATV" (6 trials), "FTC/TDF" (6 trials) and "Placebo" (6 trials). Other intervention names were less common.

The vast majority of trials in "Midway Immunology and Research Center" are 50 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Midway Immunology and Research Center". undefined are not yet recruiting, 5 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 39 completed trials in Midway Immunology and Research Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Midway Immunology and Research Center, 8 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 37 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".